Specific binding of endothelin on human vascular smooth muscle cells in culture.
AUTOR(ES)
Clozel, M
RESUMO
Endothelin is a newly discovered, potent vasoconstrictor peptide secreted by endothelial cells. The binding of endothelin was studied on cultured human vascular smooth muscle cells obtained from umbilical veins. A single specific binding site for 125I-endothelin was identified, with an apparent Kd of 126 pM and a maximal binding capacity of approximately 10,000 sites per smooth muscle cell. At room temperature the binding was saturable, reached equilibrium at 2 h (using 20 pM endothelin), and was slowly and only partially reversed by unlabeled endothelin. The calcium antagonists nifedipine, nicardipine, and diltiazem did not compete for the same binding site. Conditioned medium from cultured human umbilical vein endothelial cells inhibited the binding of 125I-endothelin dose dependently. This effect was antagonized by anti-endothelin antiserum. We conclude that human umbilical vein smooth muscle cells possess specific binding sites for endothelin, and that human endothelial cells secrete an endothelinlike material.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=303887Documentos Relacionados
- Development of smooth muscle cells in tissue culture.
- Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.
- Low-voltage-activated calcium current in rat aorta smooth muscle cells in primary culture.
- Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis.
- Effects of methyl isocyanate on rat muscle cells in culture.